Malcolm Berko//January 16, 2012//
I don’t want to lose this money, but I’m willing to take a chance if there’s a possibility that I can double my money. – TJ, Rochester, Minn.
CLWR serves 88 markets in the U.S., covering about 115 million people, plus maintains a smaller market in Europe of about 3.1 million people.
Losses are expected to drop significantly in 2012 and 2013 with a possible break-even by 2014 on an anticipated $2 billion in revenue. CLWR has a $3.58 book value, including cash of $2.80 per share with a float of 120 million shares.
Chaplin reckons that CLWR could be a $5 to $6 stock in the coming dozen months.
BSX has a nonpareil reputation in the interventional medical device industry, selling pacemakers, stents, balloon catheters, atherectomy systems, guide wires, embolic protection devices and an impressive array of other highly regarded devices.
Today, improved product development; potentially enormous revenue growth from emerging market countries such as Brazil, India, China and Argentina; and better revenue growth from the U.S. are bullish for BSX.
All margins are expected to improve, revenues should increase to $9.1 billion, earnings could double to 85 cents a share, and if Morningstar’s analysts are correct, BSX could trade in the $17 to $20 range.
In 2007 and 2008, management failed to compete with the heavy, high-value TV advertising of its bigger rivals. As a result, revenues fell and earnings crashed 80 percent.
The dividend was eliminated, capital spending was cut by 90 percent, net profit margins collapsed from 7.7 percent to 1.9 percent, and the shares imploded to a buck a share.
Earnings may double to $1.40 a share by 2014.
And fund manager Robert Olstein believes RT could trade between $15 and $18 in the next two years.
It designs, produces and markets very small-aperture terminals for cellular traffic backhaul, allowing operators to expand their market reach.
GILT also provides an emergency response/rapid deployment system that is transportable and “man-pack” communications solutions.
GILT owns 31 percent of the North American market, where it processes credit card transactions at gas stations, and its 69 percent share of state lottery transactions makes GILT very compelling.
There are 41 million outstanding shares reporting a book value of $6.71 with revenue growth potential of 9 percent to 12 percent per year over the coming three years. GILT is a favorite of money manager James Roumell, who believes the stock could double by 2014.